Skip to main content
Clinical Trials/NCT01883856
NCT01883856CompletedNot Applicable

Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves

Peter Netland, MD2 sites in 1 country52 target enrollmentStarted: February 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
52
Locations
2
Primary Endpoint
Change in Intraocular Pressure

Study Overview

Brief Summary

The purpose of this study is to evaluate and compare the clinical outcomes after implantation of the porous plate (polyethylene) (Model M4) Ahmed Glaucoma Valve with the silicone plate Ahmed Glaucoma Valve (Model FP7) in participants with refractory glaucoma.

Detailed Description

The purpose of this study is to evaluate and compare the clinical outcomes after implantation of the porous plate (polyethylene) (Model M4) Ahmed Glaucoma Valve with the silicone plate Ahmed Glaucoma Valve (Model FP7) in participants with refractory glaucoma. Participation will last for 12 months.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male or female of any race ≥ 18 years and ≤ 80 years of age.
  • Diagnosis of intractable glaucoma in the study eye, with the exception of silicone oil endotamponade induced glaucoma, which has not responded to conventional medical and surgical therapy.
  • Elevated intraocular pressure > 21 mmHg in the study eye. Two consecutive measurements using Goldmann Applanation Tonometry will be obtained and the mean of those two measurements will be considered the subject's baseline intraocular pressure.
  • Subject is a candidate for surgery in the study eye with a glaucoma drainage device.
  • Subject is willing and able to sign the informed consent.

Exclusion Criteria

  • Diagnosis of silicone oil endotamponade induced glaucoma in the study eye.
  • History of prior drainage implant surgery in the study eye.
  • History of cyclophotocoagulation of the study eye.
  • Pregnancy.
  • Prisoner.

Outcomes

Primary Outcomes

Change in Intraocular Pressure

Time Frame: 12 months

The primary endpoint is the mean intraocular pressure in the porous plate group as compared to the silicone plate group.

Secondary Outcomes

  • Anti-Glaucoma Medications(12 months)
  • Surgical Success(12 months)

Investigators

Sponsor
Peter Netland, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Peter Netland, MD

Chair, Department of Ophthalmology

University of Virginia

Study Sites (2)

Loading locations...

Similar Trials